"Top officials at Johnson & Johnson (NYSE: JNJ) are eager to acquire companies with technologies that could enhance their MedTech business. That was one of the big takeaways yesterday from the company’s earnings call. MedTech is rebounding well from the COVID-19 pandemic, with revenues up 5.9% year-over-year in the first quarter. The company is reaching […]"
Might just not be Edwards or Medtronics who are interested.
Commentary on AGM questions., page-14
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.60 | $347.8K | 23.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 760 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.15 | 388 | 1 |
View Market Depth
| Last trade - 15.58pm 30/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |